Overview
Lanfang Li practices in Tianjin, China. Li is rated as an Advanced expert by MediFind in the treatment of Peripheral T-Cell Lymphoma. Their top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Follicular Lymphoma.
Their clinical research consists of co-authoring 74 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Peripheral T-Cell Lymphoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- B-Cell LymphomaLi isDistinguished. Learn about B-Cell Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Non-Hodgkin LymphomaLi isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Advanced
- Follicular Lymphoma
- Peripheral T-Cell Lymphoma
- Experienced
- Hodgkin LymphomaLi isExperienced. Learn about Hodgkin Lymphoma.
- LeukemiaLi isExperienced. Learn about Leukemia.
- Mantle Cell Lymphoma (MCL)
- T-Cell LymphomaLi isExperienced. Learn about T-Cell Lymphoma.